Romano C, Price M T, Almli T, Olney J W
Department of Ophthalmology and Visual Sciences 63110, USA.
Invest Ophthalmol Vis Sci. 1998 Feb;39(2):416-23.
Ischemic neurodegeneration contributes to many retinal diseases. An isolated retina model has been used to examine the neuronal cell death induced by deprivation of oxygen and glucose (simulated ischemia) as a model for ischemic disease.
Neurodegeneration in the isolated chick embryo retina was induced by simulated ischemia and assessed using biochemical (lactate dehydrogenase release) and morphologic (light microscopy) techniques.
Simulated ischemia led to lactate dehydrogenase release gradually in a period of 6 to 24 hours. Light microscopic observations demonstrated morphologic cell degeneration well before lactate dehydrogenase release occurred. N-Methyl-D-aspartate (NMDA) and non-NMDA receptor blockers individually provided partial protection, and the combination was fully protective. No protection was provided if the antagonists were added after simulated ischemia. When NMDA receptors were blocked by MK-801, cyclothiazide, an inhibitor of desensitization at non-NMDA receptors, enhanced lactate dehydrogenase released after 1 or 2 hours of simulated ischemia. Low concentrations of glucose effectively prevented lactate dehydrogenase release, despite anoxic conditions.
The isolated retina provided a convenient system to characterize quantitatively ischemic cell death. Retinal ischemic neurodegeneration is an excitotoxic process that involves overactivation of NMDA and non-NMDA glutamate receptors. Blockade of both of these receptor subtypes was necessary for complete neuroprotection. Receptor desensitization played a protective role. If even low concentrations of glucose were delivered to an ischemic retina in vitro, substantial neuroprotection could be achieved. This may have implications for the management of acute retinal ischemic episodes.
缺血性神经变性与多种视网膜疾病相关。分离视网膜模型已被用于研究因缺氧和缺糖(模拟缺血)诱导的神经元细胞死亡,以此作为缺血性疾病的模型。
通过模拟缺血诱导分离的鸡胚视网膜发生神经变性,并使用生化技术(乳酸脱氢酶释放)和形态学技术(光学显微镜)进行评估。
模拟缺血在6至24小时内导致乳酸脱氢酶逐渐释放。光学显微镜观察显示,在乳酸脱氢酶释放之前就已出现形态学上的细胞变性。N-甲基-D-天冬氨酸(NMDA)和非NMDA受体阻滞剂单独使用时提供部分保护,两者联合使用则具有完全保护作用。如果在模拟缺血后添加拮抗剂则无保护作用。当NMDA受体被MK-801阻断时,非NMDA受体脱敏抑制剂环噻嗪会增强模拟缺血1或2小时后的乳酸脱氢酶释放。尽管处于缺氧条件下,低浓度葡萄糖仍能有效防止乳酸脱氢酶释放。
分离视网膜提供了一个便于定量表征缺血性细胞死亡的系统。视网膜缺血性神经变性是一个兴奋性毒性过程,涉及NMDA和非NMDA谷氨酸受体的过度激活。同时阻断这两种受体亚型对于完全神经保护是必要的。受体脱敏发挥了保护作用。如果向体外缺血视网膜输送即使是低浓度的葡萄糖,也可实现显著的神经保护。这可能对急性视网膜缺血发作的治疗具有启示意义。